Source: Clinical rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, IMUNOGENICIDADE DA VACINA, INFLUENZA
ABNT
PASOTO, Sandra Gofinet et al. Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjogren syndrome. Clinical rheumatology, v. 42, n. 9, p. 2419-2425, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55988. Acesso em: 18 nov. 2024.APA
Pasoto, S. G., Borba Neto, E. F., Formiga, F. F. C., Pedrosa, T. do N., Aikawa, N. E., Leon, E. P., et al. (2023). Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjogren syndrome. Clinical rheumatology, 42( 9), 2419-2425. doi:10.1007/s10067-023-06666-wNLM
Pasoto SG, Borba Neto EF, Formiga FFC, Pedrosa T do N, Aikawa NE, Leon EP, Lopes MH, Duarte AJ da S, Silva CAA da, Bonfa ESD de O. Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjogren syndrome [Internet]. Clinical rheumatology. 2023 ; 42( 9): 2419-2425.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55988Vancouver
Pasoto SG, Borba Neto EF, Formiga FFC, Pedrosa T do N, Aikawa NE, Leon EP, Lopes MH, Duarte AJ da S, Silva CAA da, Bonfa ESD de O. Robust immunogenicity to the H3N2 component of influenza A vaccine in primary Sjogren syndrome [Internet]. Clinical rheumatology. 2023 ; 42( 9): 2419-2425.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55988